Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 May;75(9):890-7.
doi: 10.1038/ki.2008.644. Epub 2009 Jan 14.

The emerging role of phosphate in vascular calcification

Affiliations
Review

The emerging role of phosphate in vascular calcification

Cecilia M Giachelli. Kidney Int. 2009 May.

Abstract

Vascular calcification is recognized as a major contributor to cardiovascular disease (CVD) in end stage renal disease (ESRD) patients. Susceptibility to vascular calcification is genetically determined and actively regulated by diverse inducers and inhibitors. One of these inducers, hyperphosphatemia, promotes vascular calcification and is a nontraditional risk factor for CVD mortality in ESRD patients. Vascular smooth muscle cells (SMCs) respond to elevated phosphate levels by undergoing an osteochondrogenic phenotype change and mineralizing their extracellular matrix through a mechanism requiring sodium-dependent phosphate cotransporters. Disease states and cytokines can increase expression of sodium-dependent phosphate cotransporters in SMCs, thereby increasing susceptibility to calcification even at phosphate concentrations that are in the normal range.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Major Theories of Vascular Calcification Six different mechanisms that have been proposed to regulate the initiation or progression of vascular calcification are illustrated, along with key molecular mediators where known. The extent to which each of these mechanisms plays a role in vascular calcification in various disease states, including hyperphosphatemia and ESRD, is currently unknown.
Fig. 2
Fig. 2
Proposed Role of Elevated Phosphate (Pi) in Osteochondrogenic Phenotype Change and Matrix Mineralization in Vascular SMC. Pi enters the cell through the sodium dependent phosphate cotransporters, Pit-1, and induces an osteochondrogenic phenotype change. This stimulates matrix vesicle calcium and Pi loading, as well as matrix changes that promote calcification. Molecules involved in regulating Pi loading of matrix vesicles or Pi efflux are currently unknown.

Similar articles

Cited by

References

    1. Hunt JL, Fairman R, Mitchell ME, et al. Bone formation in carotid plaques: a clinicopathological study. Stroke. 2002;33:1214–1219. - PubMed
    1. Burke AP, Taylor A, Farb A, et al. Coronary calcification: insights from sudden coronary death victims. Z Kardiol. 2000;89 (Suppl 2):49–53. - PubMed
    1. Monckeberg JG. Uber die reine mediaverkalkung der extremitaten-arteries und ihr Verhalten zur arteriosklerose. Virchows Arch. 1903;171:141–167.
    1. Edmonds ME, Morrison N, Laws JW, et al. Medial arterial calcification and diabetic neuropathy. Br Med J (Clin Res Ed) 1982;284:928–930. - PMC - PubMed
    1. Micheletti RG, Fishbein GA, Currier JS, et al. Monckeberg sclerosis revisited: a clarification of the histologic definition of Monckeberg sclerosis. Arch Pathol Lab Med. 2008;132:43–47. - PubMed

Publication types

MeSH terms